TLSA Company Profile and Key Details

Q: Who are the executives of TLSA?

Dr. Napoleone Ferrara M.D.Member of Scientific Advisory BoardDr. Andrea BrancaleScientific FounderMr. Richard Clarkson Ph.D.Scientific FounderProf. Roberto Pellicciari Ph.D.ConsultantMr. Andrew Westwell Ph.D.Scientific FounderProf. Napoleone Ferrara M.D.Member of Scientific Advisory BoardDr. Matthew W. Davis M.D., R.Ph., RPhChief Operating Officer & Chief Medical OfficerDr. Matthew W. Davis M.D., RPhChief Operating Officer, Chief Medical Officer & Acting Chief Scientific Officer

NASDAQ : TLSA

Tiziana Life Sciences

$0.77

-0.0819-9.61%

At Close 4:00 PM

63.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tiziana Life Sciences Ltd (TLSA) stock declined over -9.61%, trading at $0.77 on NASDAQ, down from the previous close of $0.85. The stock opened at $0.86, fluctuating between $0.76 and $0.88 in the recent session.

Stock Snapshot

0.852

Prev. Close

49M

Market Cap

0.7615

Day Low

-2.43

P/E Ratio

-0.31642

EPS (TTM)

-0.08

Cash Flow per Share

0.86

Open

63.63M

Number of Shares

0.88

Day High

55.81%

Free Float in %

0.13

Book Value

844.51K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 16, 2026	0.85	0.88	0.76	0.77	843.64K
Sep 15, 2026	0.89	0.89	0.81	0.85	659.15K
Sep 14, 2026	0.96	0.98	0.89	0.89	563.93K
Sep 11, 2026	0.98	1.00	0.93	0.96	272.92K
Sep 10, 2026	0.96	0.98	0.95	0.96	194.61K
Sep 09, 2026	0.99	1.01	0.95	0.98	245.45K
Sep 08, 2026	1.02	1.03	0.96	0.99	908.22K
Sep 04, 2026	0.97	1.06	0.95	1.02	573.92K
Sep 03, 2026	1.05	1.05	0.95	0.97	514.98K
Sep 02, 2026	0.96	1.00	0.91	0.93	487.84K
Sep 01, 2026	0.99	1.00	0.91	0.96	515.06K
Aug 31, 2026	1.02	1.05	0.97	0.99	429.67K
Aug 28, 2026	1.10	1.10	1.00	1.01	565.52K
Aug 27, 2026	1.09	1.14	1.05	1.08	272.31K
Aug 26, 2026	1.12	1.13	1.08	1.09	402.64K
Aug 25, 2026	1.18	1.18	1.10	1.11	440.96K
Aug 24, 2026	1.14	1.25	1.14	1.15	959.02K
Aug 21, 2026	1.12	1.17	1.09	1.14	832.31K
Aug 20, 2026	1.08	1.16	1.04	1.12	1.57M
Aug 19, 2026	1.12	1.17	1.02	1.07	2.08M

Contact Details

London, W1S 2XJ

United Kingdom

https://www.tizianalifesciences.com 442 074 952379

About Company

Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.

Stock Peers

ARGX

4.93+0.50%

argenx SE$984.69 REGN

0.5+0.06%

Regeneron Pharmaceuticals, Inc.$774.61 MDGL

5.83+1.11%

Madrigal Pharmaceuticals, Inc.$529.09 VRTX

-1.37-0.27%

Vertex Pharmaceuticals Incorporated$513.26 UTHR

-1.87-0.37%

United Therapeutics Corporation$498.48 ONC

1.58+0.46%

BeOne Medicines AG$348.08 KRYS

-0.010.00%

Krystal Biotech, Inc.$336.67 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-3.91-1.25%

Praxis Precision Medicines, Inc.$308.99 LGND

-1.78-0.64%

Ligand Pharmaceuticals Incorporated$275.20

Frequently Asked Questions

What is the current Tiziana Life Sciences Ltd (TLSA) stock price?

Tiziana Life Sciences Ltd (NASDAQ: TLSA) stock price is $0.77 in the last trading session. During the trading session, TLSA stock reached the peak price of $0.88 while $0.76 was the lowest point it dropped to. The percentage change in TLSA stock occurred in the recent session was -9.61% while the dollar amount for the price change in TLSA stock was - $0.08.

TLSA's industry and sector of operation?

The NASDAQ listed TLSA is part of Biotechnology industry that operates in the broader Healthcare sector. Tiziana Life Sciences Ltd designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TLSA?

Dr. Napoleone Ferrara M.D.
Member of Scientific Advisory Board
Dr. Andrea Brancale
Scientific Founder
Mr. Richard Clarkson Ph.D.
Scientific Founder
Prof. Roberto Pellicciari Ph.D.
Consultant
Mr. Andrew Westwell Ph.D.
Scientific Founder
Prof. Napoleone Ferrara M.D.
Member of Scientific Advisory Board
Dr. Matthew W. Davis M.D., R.Ph., RPh
Chief Operating Officer & Chief Medical Officer
Dr. Matthew W. Davis M.D., RPh
Chief Operating Officer, Chief Medical Officer & Acting Chief Scientific Officer

How TLSA did perform over past 52-week?

TLSA's closing price is 1.13% higher than its 52-week low of $0.76 where as its distance from 52-week high of $2.35 is -67.23%.

How many employees does TLSA have?

Number of TLSA employees currently stands at 10.

Link for TLSA official website?

Official Website of TLSA is: https://www.tizianalifesciences.com

How do I contact TLSA?

TLSA could be contacted at phone 442 074 952379 and can also be accessed through its website. TLSA operates from 14/15 Conduit Street, London, W1S 2XJ, United Kingdom.

How many shares of TLSA are traded daily?

TLSA stock volume for the day was 844.51K shares. The average number of TLSA shares traded daily for last 3 months was 595.35K.

What is the market cap of TLSA currently?

The market value of TLSA currently stands at $49.00M with its latest stock price at $0.77 and 63.63M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	10
Beta	0.46
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	10
Beta	0.46
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TLSA Company Profile and Key Details

Tiziana Life Sciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook